Skip to content
OpenCapital
Get started

Harrow HROW IHEEZO — Revenue

Other product segments

VEVYE
$20.95M-2.6%
Other Products
$7.83M+719%
Other Revenues
$73K—

Similar metrics at other companies

WisdomTree logo
WTIE — Revenue (Gross)
$13.94M+132%
Nuvation Bio logo
NUVBProduct Revenue — Revenue
$18.5M+2,213%
H.B. Fuller logo
FULEIMEA — Revenue (Gross)
$232.94M-1.4%
LQD
LQDAProduct — Revenue
$129.88M—
Syndax Pharmaceuticals logo
SNDXProduct — Revenue
$48.92M+144%
PTC Therapeutics logo
PTCTProduct — Revenue
$225.57M+47.0%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's iheezo — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's IHEEZO — revenue?
Harrow (HROW) reported IHEEZO — revenue of $1.85M in Q1 2026.
How has Harrow's IHEEZO — revenue changed year-over-year?
Harrow's IHEEZO — revenue decreased by 64.6% year-over-year, from $5.22M to $1.85M.
What does IHEEZO — revenue mean?
This metric represents the total gross revenue generated from the sale of a specific pharmaceutical product or service line, net of any assessed taxes. It serves as a primary indicator of market adoption and commercial success for the product within the company's portfolio. Tracking this figure allows investors to evaluate the growth trajectory and revenue contribution of the specific segment relative to the company's overall financial performance.